Interleukin-5: an indicator of mild cognitive impairment in patients with type 2 diabetes mellitus - a comprehensive investigation ranging from bioinformatics analysis to clinical research
IL-5 is considered a risk factor for MCI in T2DM patients and is associated with their performance in information processing speed. Moreover, an elevated level of IL-5 is a plausible biomarker for MCI in T2DM patients.
Authors
- Zhen Zhang (ORCID: https://orcid.org/0000-0002-0804-8741)
- Hongxiao Wang (ORCID: https://orcid.org/0000-0001-6948-7329)
- Shufang Yang
- Haoqiang Zhang (ORCID: https://orcid.org/0000-0001-6937-4252)
- Linlin Xu (ORCID: https://orcid.org/0000-0002-3488-5199)
- Jumei Wang
- Tong Niu
- Bing Song (ORCID: https://orcid.org/0000-0001-7750-4635)
- Sumei Li (ORCID: https://orcid.org/0000-0002-5450-8235)
- Hui Zhang (ORCID: https://orcid.org/0000-0002-9065-6956)
- Wenwen Zhu (ORCID: https://orcid.org/0009-0005-5433-4094)
- Huzaifa Fareeduddin Mohammed Farooqui
Institutions
- University of Science and Technology of China (CN)
- Nantong University (CN)
- Zhongda Hospital Southeast University (CN)
- The Affiliated Taizhou People's Hospital of Nanjing Medical University (CN)
- First Affiliated Hospital of Henan University of Science and Technology (CN)
- Jinzhou Medical University (CN)
Publication Details
- Journal
- Journal of Endocrinological Investigation
- Published
- 2024-09-30
- DOI
- https://doi.org/10.1007/s40618-024-02430-2
- Citations
- 4
- Primary Topic
- Neuroinflammation and Neurodegeneration Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.99
Funders
- China Postdoctoral Science Foundation
- University of Science and Technology of China
- China International Medical Foundation